Menu Menu

RLAY    Relay Therapeutics Inc    1812364    
Income Statement
Revenue rlay-20240930 10,007,000
Net Income rlay-20240930 -88,105,000
Profit Margin -880.43%

Balance Sheet
Current Assets 865,129,000
Assets 930,115,000
Current Liabilities 46,968,000
Liabilities 91,254,000
Equity 838,861,000
Shares Out 162,461,000

Cash Flow Statement
Operating Cash Flow -191,239,000
Investing Cash Flow -70,081,000

Market Analysis
Market Cap 1,283,837,631
Price 4.46
BVPS 5.16
PB 0.86
EPS -2.52
PS 32.07
FCF -261,320,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/22 -0.67
Apr May Jun
5/02 -0.62
Jul Aug Sep
8/06 -0.69
Oct Nov Dec
10/31

Find a discrepancy? The most accurate way to find company fundamental data is to view RLAY documents filed with the SEC.


RLAY Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas